Article Details
Retrieved on: 2024-06-07 21:19:14
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses strategies for managing adverse events in multiple myeloma treatments, focusing on biotech therapies like bortezomib. This relates to the key concept and tags by addressing the use of biotech solutions in therapy, particularly for orphan drugs targeting diseases like multiple myeloma.
Article found on: www.targetedonc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here